UNSPSC 51402502: Gedocarnil

This classification denotes an anxiolytic with the molecular formula C23H21ClN2O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BWP53NPW3F, chemically known as isopropyl 5-(p-chlorophenoxy)-4-(methoxymethyl)-9h-pyrido(3,4-b)indole-3-carboxylate. but generally known as gedocarnil, which bears US NIH Compound Identifier 219095. European Medicines Agency schedules Gedocarnil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07888MIG. The term GEDOCARNIL is an International Non-Proprietary Name.

UNSPSC 51402502 Gedocarnil is a Commodity code that does not align with the state and local procurement activity tagged under it. The single recent opportunity in the dataset — Seminole County, Florida's IFB60459723LAS for naloxone and drug deactivation systems — involves harm-reduction pharmaceuticals and medical devices wholly unrelated to gedocarnil, a pharmaceutical compound outside the scope of typical state and local government purchasing. The mismatch suggests either a cataloging error in the source or a misclassification of the opportunity at posting. No additional recent solicitations under this code appear in the current dataset, leaving the Commodity's actual procurement footprint unclear.

Seminole County released IFB 60459723LAS on June 30, 2026, with a response deadline of July 26, 2023 (note: the date appears inconsistent within the source), seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually on a two-year initial term with one-year renewal option. Quarterly deliveries were required to the Seminole County Community Health Building in Sanford, Florida. Bidders had to include all shipping and delivery costs, comply with drug-free workplace certification and E-Verify requirements, and maintain workers' compensation, commercial general liability, and professional liability insurance. The procurement noted potential FEMA funding and associated federal compliance obligations. Without additional opportunities or issuing bodies in the dataset, assessment of geographic spread or typical buyer concentration under this code is not possible.